Clinical application of adoptive T cell therapy in solid tumors.

Med Sci Monit · 2014 · PMC4063985 · PMID 24912947

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In 1993, a prospective randomized trial showed a trend toward improved survival in patients with melanoma receiving IL-2 plus LAK cells compared with IL-2 only, but no difference in survival was seen in patients with renal cell cancer (RCC) in the 2 treatment groups [ 11 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.